Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jan Novak
Columbia University Health Sciences, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Reliant Glycosciences, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The outcome of the research is of significant business interest to the entity and therefore the financial interest could likely change based on the research results.
Aptamer-Based Arrays for Detection of Pathogenic IgA1 O-Glycoforms in IgA Nephropathy
Complex saccharide structures ('glycans') play crucial roles in a wide range of biological functions and diseases such as autoimmunity, cancer, and nephropathy. We will help elucidate the role of complex glycans in the pathogenesis of IgA nephropathy, one of the most common causes of kidney failure worldwide, by systematically and exhaustively generating oligonucleotide-based receptors (aptamers) for glycan clusters on IgA1 antibodies. This will allow new diagnostic protocols based on pattern recognition with classification arrays and, in the long-term, personalized therapies to prevent antigen-autoantibody interaction and nephropathy.
Filed on February 08, 2017.
Tell us what you know about Jan Novak's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jan Novak”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jan Novak | University of Alabama at Birmingham | Conflict of Interest | RELIANT GLYCOSCIENCES, LLC | $0 - $4,999 |
| Jan Novak | University of Alabama at Birmingham | Conflict of Interest | RELIANT GLYCOSCIENCES, LLC | $0 - $4,999 |
| Jan Novak | Columbia University Health Sciences | Conflict of Interest | Reliant Glycosciences, LLC | $0 - $4,999 |
| Jan Novak | Columbia University Health Sciences | Conflict of Interest | Reliant Glycosciences, LLC | $0 - $4,999 |
| Jan Novak | University of Alabama at Birmingham | Conflict of Interest | RELIANT GLYCOSCIENCES, LLC | $0 - $4,999 |
| Jan Novak | University of Alabama at Birmingham | Conflict of Interest | RELIANT GLYCOSCIENCES, LLC | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.